Accuray Incorporated recalls TomoHDA(R) System, Model Number 1018286 Product Usage: The TomoTherapy treatment system is intended to be used as an in…
- Recall date
- November 17, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0289-2018
- FDA classification
- Class II
- Brand / firm
- Accuray Incorporated
- Sold / distributed
- Worldwide Distribution
Why it was recalled
Uncontrolled couch Z-axis movement (descent)
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
TomoHDA(R) System, Model Number 1018286 Product Usage: The TomoTherapy treatment system is intended to be used as an integrated system for t he planning and precise delivery of radiation therapy, stereotactic radiotherapy, or stereotactic radiosurgery to tumors or other targeted tissues while minimizing the delivery of radiation to vital healthy tissues. The megavoltage x-ray radiation is delivered in a rotational, non-rotational, modulated (IMRT), or non- modulated (non-IMRT/3 dimensional conformal) format in accordance with the physicians prescribed and approved plan.
Get recall alerts
Free email alert whenever Accuray Incorporated has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Accuray Incorporated